CAUWENBERGH GEERT (President & CEO) received a stock award from PHIO PHARMACEUTICALS CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/1/2019ACC: 0001209191-19-014816
DirectorOfficer· President & CEO
Since Aug 2018
+152.41K
Net shares
Net buyer
$57.9K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
152.41K acquired
Non-Derivative Transactions1
Common stock, $0.0001 par value
Direct
Shares
+152.41K
Price / share
$0.38
Trade value
$57.89K
% of position
46.3%
2/28/2019
329.18K→481.59K
Total
Net shares
+152.41K
Net value
$57.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value Direct | 2/28/2019 | A · Award | +152.41K | $0.38 | $57.89K | 46.3% | 329.18K | 481.59K |
| Total | +152.41K | $57.89K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common stock, $0.0001 par value
IndirectShares owned450.00
Total
450.00 indirect450.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock, $0.0001 par value | 450.00 | Indirect |
| Total | 450.00 | 450.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported